SISCAPA Assay Technologies
Matt has more than 9 years experience with the SISCAPA team and was the first employee of SISCAPA Assay Technologies. He manages several functions within the company including project, operations, and facilities management. He played a lead role in managing the generation and characterization of SISCAPA antibodies in the NCI Clinical Proteomic Technology Assessment for Cancer (CPTAC) Initiative. This included developing advanced techniques for measuring anti-peptide antibody affinity and associated strategies for selection of high-affinity SISCAPA reagents. Matt has a unique and varied work history including guiding numerous expeditions in the Antarctic and Arctic, leading whale-watching excursions off the coast of Vancouver Island, and worked as a visiting scientist at the International Livestock Research Institute in Nairobi, Kenya.
This person is not in the org chart
This person is not in any offices
SISCAPA Assay Technologies
SISCAPA technology is the smart shortcut to the sensitive quantitation of protein biomarkers and targets. SISCAPA assays combine the precision of MRM mass spectrometry with the power of affinity enrichment to deliver a superior alternative to conventional immunoassays for protein quantitation.